Merrill Lynch, Linklaters, PwC, Marsh and ERM advised 3i, with debt facilities provided by GE, Calyon Credit Agricole CIB, Danske Bank, European Capital and HSH Nordbank.
Oslo-based Active Pharmaceutical Ingredients, a division of NYSE-listed
The business has manufacturing facilities in Copenhagen, Oslo, Budapest and Taizhou in China, employs 700 staff and generated approximately US$138.7m in revenues in the first nine months of 2007.
3i industrialist in residence Peter Chambré has been appointed as a non-executive chairman to the company. 3i’s track record in pharmaceuticals includes Betapharm, sold in 2006 to India’s Dr Reddy’s Labs, and Domantis, sold to GlaxoSmithKline, also in 2006.